XORTX Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-1.476; its P/E ratio is -2.26; XORTX Therapeutics Inc is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	C$ 2.70M	C$ -1.33M	C$ -1.69M	C$ -1.83M	C$ -2.99M
EBITDA	C$ 2.72M	C$ -1.32M	C$ -1.66M	C$ -1.77M	-
Net Income Common Stockholders	C$ 2.70M	C$ -1.33M	C$ -1.69M	C$ -1.83M	C$ -2.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 3.45M	C$ 5.07M	C$ 6.16M	C$ 7.91M	C$ 14.13M
Total Assets	C$ 5.47M	C$ 6.64M	C$ 7.80M	C$ 9.66M	C$ 16.75M
Total Debt	C$ 11.51K	C$ 28.51K	C$ 45.19K	C$ 61.54K	C$ 105.11K
Net Debt	C$ -3.44M	C$ -5.04M	C$ -6.12M	C$ -7.85M	C$ -14.02M
Total Liabilities	C$ 825.94K	C$ 553.76K	C$ 403.26K	C$ 599.79K	C$ 7.29M
Stockholders Equity	C$ 4.64M	C$ 6.09M	C$ 7.40M	C$ 9.06M	C$ 9.47M
Cash Flow	-
Free Cash Flow	C$ -1.31M	C$ -1.08M	C$ -1.74M	C$ -2.50M	C$ -5.18M
Operating Cash Flow	C$ -1.30M	C$ -1.07M	C$ -1.73M	C$ -2.48M	C$ -5.16M
Investing Cash Flow	C$ -9.79K	C$ -7.30K	C$ -9.54K	C$ -19.73K	C$ -21.68K
Financing Cash Flow	C$ -312.25K	C$ -16.67K	C$ -8.76K	C$ -23.36K	C$ 7.07M

Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

Income Statement >

XORTX Therapeutics Inc Debt to Assets

Balance Sheet >

XORTX Therapeutics Inc Cash Flow

Cash Flow >

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing